D. van Baarle

714 total citations
21 papers, 562 citations indexed

About

D. van Baarle is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, D. van Baarle has authored 21 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Immunology and 8 papers in Oncology. Recurrent topics in D. van Baarle's work include Immune Cell Function and Interaction (10 papers), Cytomegalovirus and herpesvirus research (9 papers) and Viral-associated cancers and disorders (8 papers). D. van Baarle is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Cytomegalovirus and herpesvirus research (9 papers) and Viral-associated cancers and disorders (8 papers). D. van Baarle collaborates with scholars based in Netherlands, United States and Germany. D. van Baarle's co-authors include Nening M. Nanlohy, Suzanne van Dorp, Frank Miedema, Jürgen Kuball, Erwan Piriou, Bodo Plachter, Sabine Heijhuurs, Victoria Marcu‐Malina, Samantha Hol and David Vermijlen and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Leukemia.

In The Last Decade

D. van Baarle

21 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. van Baarle Netherlands	11	343	311	184	98	96	21	562
Maud Brandely France	12	209 0.6×	223 0.7×	128 0.7×	44 0.4×	98 1.0×	19	635
N. E. Annels Netherlands	5	266 0.8×	602 1.9×	315 1.7×	87 0.9×	39 0.4×	7	815
María José Remigia Spain	16	476 1.4×	174 0.6×	168 0.9×	161 1.6×	133 1.4×	30	709
J Maciejewski United States	11	336 1.0×	345 1.1×	128 0.7×	65 0.7×	370 3.9×	23	852
Sophie Ravet France	10	175 0.5×	366 1.2×	80 0.4×	37 0.4×	49 0.5×	14	583
Anne Christin United States	7	366 1.1×	256 0.8×	417 2.3×	106 1.1×	102 1.1×	11	699
Paula Amat Spain	16	351 1.0×	127 0.4×	126 0.7×	115 1.2×	153 1.6×	46	625
María Helena Thomaz Maia Brazil	8	81 0.2×	422 1.4×	90 0.5×	61 0.6×	69 0.7×	10	691
Ketevan Gendzekhadze United States	13	112 0.3×	555 1.8×	80 0.4×	127 1.3×	143 1.5×	42	786
H. Kikuta Japan	11	160 0.5×	145 0.5×	131 0.7×	147 1.5×	69 0.7×	16	433

Countries citing papers authored by D. van Baarle

Since Specialization

Citations

This map shows the geographic impact of D. van Baarle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van Baarle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van Baarle more than expected).

Fields of papers citing papers by D. van Baarle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. van Baarle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van Baarle. The network helps show where D. van Baarle may publish in the future.

Co-authorship network of co-authors of D. van Baarle

This figure shows the co-authorship network connecting the top 25 collaborators of D. van Baarle. A scholar is included among the top collaborators of D. van Baarle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. van Baarle. D. van Baarle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scheper, Wouter, Suzanne van Dorp, Sabina Kersting, et al.. (2013). γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia. 27(6). 1328–1338. 149 indexed citations

Schuurman, Rob, Martin Schutten, Jan J. Cornelissen, et al.. (2013). Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT. Bone Marrow Transplantation. 48(11). 1460–1464. 21 indexed citations

Sutherland, Jayne S., André G. Loxton, Mariëlle C. Haks, et al.. (2013). Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clinical Microbiology and Infection. 20(4). O230–O238. 58 indexed citations

Boelens, Jaap Jan, Ronald Jacobi, Rob Schuurman, et al.. (2013). Increased proportion of perforin-expressing CD8+T-cells indicates control of herpesvirus reactivation in children after stem cell transplantation. Clinical Immunology. 148(1). 92–98. 6 indexed citations

Keşmir, Can, et al.. (2012). Protective HLA Molecules Determine Infection Outcome by Preferential Presentation of Peptides From Conserved Hepatitis C Proteins. Immunology. 137. 483–483. 1 indexed citations

Oosterom, A. van, et al.. (2012). Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient. Transplant Immunology. 27(1). 48–51. 5 indexed citations

Pagter, Anne P.J. de, Jaap Jan Boelens, Kiki Tesselaar, et al.. (2012). First analysis of human herpesvirus 6T-cell responses: Specific boosting after HHV6 reactivation in stem cell transplantation recipients. Clinical Immunology. 144(3). 179–189. 8 indexed citations

Pagter, Anne P.J. de, D. van Baarle, Nening M. Nanlohy, et al.. (2012). Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease. Bone Marrow Transplantation. 48(4). 502–507. 4 indexed citations

Oostvogels, Rimke, Monique C. Minnema, Robbert M. Spaapen, et al.. (2012). Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. Leukemia. 27(3). 642–649. 22 indexed citations

10.

Arends, Joop E., et al.. (2011). Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells. APOPTOSIS. 16(9). 959–966. 11 indexed citations

11.

Dorp, Suzanne van, Monique C. Minnema, Jürgen Kuball, et al.. (2011). Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients. Clinical Infectious Diseases. 52(7). e144–e148. 17 indexed citations

12.

Dorp, Suzanne van, Ronald Jacobi, Nening M. Nanlohy, et al.. (2010). High Level of Perforin Expression in T Cells: An Early Prognostic Marker of the Severity of Herpesvirus Reactivation after Allogeneic Stem Cell Transplantation in Adults. Clinical Infectious Diseases. 50(5). 717–725. 9 indexed citations

13.

Berg, Charlotte H. S. B. van den, Nening M. Nanlohy, Suzanne E. Geerlings, et al.. (2009). Comprehensive longitudinal analysis of hepatitis C virus (HCV)‐specific T cell responses during acute HCV infection in the presence of existing HIV‐1 infection. Journal of Viral Hepatitis. 16(4). 239–248. 7 indexed citations

14.

Arends, Joop E., James Cohen Stuart, Lubbertus C. Baak, et al.. (2009). Plasma HCV‐RNA decline in the first 48 h identifies hepatitis C virus mono‐infected but not HCV/HIV‐coinfected patients with an undetectable HCV viral load at week 4 of peginterferon‐alfa‐2a/ribavirin therapy. Journal of Viral Hepatitis. 16(12). 867–875. 9 indexed citations

15.

Nanlohy, Nening M., Charlotte H. S. B. van den Berg, Elly A. Hassink, et al.. (2008). HCV‐specific T‐cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance. Journal of Viral Hepatitis. 15(6). 409–420. 16 indexed citations

16.

Piriou, Erwan, et al.. (2008). Detailed analysis of Epstein–Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis. Clinical & Experimental Immunology. 153(2). 231–239. 36 indexed citations

17.

Piriou, Erwan, et al.. (2007). Tight Regulation of the Epstein-Barr Virus Setpoint: Interindividual Differences in Epstein-Barr Virus DNA Load Are Conserved after HIV Infection. Clinical Infectious Diseases. 46(2). 313–316. 10 indexed citations

18.

Annels, Nicola, Jayant Kalpoe, Robbert G. M. Bredius, et al.. (2006). Management of Epstein-Barr Virus (EBV) Reactivation after Allogeneic Stem Cell Transplantation by Simultaneous Analysis of EBV DNA Load and EBV-Specific T Cell Reconstitution. Clinical Infectious Diseases. 42(12). 1743–1748. 50 indexed citations

19.

Palmer, N., Christine A. Jansen, Geertje H. A. Westerlaken, et al.. (2005). Dynamics of Cytomegalovirus (CMV)–Specific T Cells in HIV‐1–Infected Individuals Progressing to AIDS with CMV End‐Organ Disease. The Journal of Infectious Diseases. 191(6). 873–880. 49 indexed citations

20.

Al‐Homsi, A. Samer, Christoph Berger, D. van Baarle, et al.. (1998). Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection.. International Journal of Molecular Medicine. 1(6). 983–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact